Ledger.Open graph →
SEC Form D · filed May 11, 2017

Innovate Biopharmaceuticals Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Jay P. Madan · Raleigh, NCExec · Director · PromoterSandeep Laumas · Raleigh, NCExec · DirectorJohn Bykowski · Hayward, CAExec · Director · PromoterScott Zeilinger · New York, NYExec · DirectorKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗